Vera Therapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Sofinnova Venture Partners X and affiliated entities have reduced their beneficial ownership in Vera Therapeutics, Inc. to below 5% due to dilution and open market sales.